Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy

NCT03860935 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

632

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyloidosis
Amyloid Cardiomyopathy
Transthyretin Amyloidosis
Cardiomyopathies
Heart Diseases

Interventions

DRUG: acoramidis
DRUG: Placebo Oral Tablet

Sponsor

Eidos Therapeutics, a BridgeBio company